This
revised guidance includes a description of the types of safety labelling
changes that ordinarily might be required under this section; how FDA plans to
determine what constitutes new safety information; the procedures involved in
requiring safety labelling changes; and enforcement of the requirements for
safety labelling changes.
Posted by Tim Sandle
No comments:
Post a Comment
Pharmaceutical Microbiology Resources